Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,093,948
+$1,319,193 QoQ
Shares Held
20,243
+16.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#1,299
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL MCLEOD PUGH & WILLIAMS INC holds $30,637,991 across 10 Drug Manufacturers - General names. ABBV ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,466 | $8,954,945 | |
| 2 | JNJ |
Johnson & Johnson
|
28,718 | $7,293,509 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
20,243 | $5,093,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,603 | $3,289,985 | |
| 5 | PFE |
Pfizer Inc
|
69,337 | $1,669,634 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,456 | $1,121,054 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,716 | $1,101,179 | |
| 8 | AMGN |
Amgen Inc
|
2,634 | $953,824 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,093,948 | 20,243 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,774,755 | 17,356 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,967,956 | 17,366 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $3,511,766 | 15,167 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,754,600 | 14,840 | Shares | Other | 2025-07-28 | |
| 2025-03-31 | $3,243,997 | 15,483 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $2,728,227 | 15,353 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $3,156,915 | 15,986 | Shares | Other | 2024-11-04 | |
| 2024-06-30 | $2,737,286 | 15,959 | Shares | Other | 2024-07-31 | |
| 2024-03-31 | $2,905,950 | 15,958 | Shares | Other | 2024-05-01 | |
| 2023-12-31 | $2,540,887 | 16,396 | Shares | Other | 2024-02-05 | |
| 2023-09-30 | $2,462,322 | 16,519 | Shares | Other | 2023-10-20 | |
| 2023-06-30 | $2,174,137 | 16,137 | Shares | Other | 2023-08-08 | |
| 2023-03-31 | $2,507,846 | 15,736 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,541,478 | 15,726 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,186,279 | 16,290 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,398,791 | 15,662 | Shares | Sole | 2022-11-18 | |
| 2022-03-31 | $2,638,826 | 16,278 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $2,208,779 | 16,313 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,752,024 | 16,242 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,806,858 | 16,041 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $1,727,299 | 15,961 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,680,968 | 15,688 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,347,658 | 15,386 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,508,044 | 15,360 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $813,327 | 10,675 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||